Thursday, September 16

tercera dosis

Covid 19, dosis de refuerzo, Noticias, Salud, tercera dosis, vacunas

Sharp Scientists: Booster Vaccine Not Appropriate | Digital Trends Spanish

Vaccination campaigns against COVID-19 continue to increase the differences in the world. While poorer countries still have a very small percentage of their population vaccinated, nations with more resources already have a vaccination schedule over 75% with the two doses, and some are even putting third or booster doses to increase the level of protection. However, this Monday, September 13, a new study launched by the specialized magazine The Lancet, with the opinion of leading world scientists and the United States, firmly states that these booster doses are not necessary and are not appropriate for the particular moment of the pandemic. While the effectiveness of the Covid vaccine against mild illness may decrease over time, protection against severe illness may persist, the scienti...
Cepas, coronavirus, Covid 19, mutaciones, Noticias, Pfizer, Salud, tercera dosis, vacunas, variante, Variante Mu

Mu variant could evade certain antibodies | Digital Trends Spanish

Health authorities in the United States are evaluating the severity of the Mu variant of the coronavirus and the impact it could have compared to other mutations. According to Anthony Fauci, the country's top epidemiologist and White House advisor on this matter, this variant could circumvent the protection offered by some types of antibodies. In conversation with the CBS channel, the professional explained: "The concern is that it has a constellation of mutations that would suggest that it can evade the protection of certain antibodies." Fauci also explained that the United States still does not have enough data to determine the efficacy of anti-COVID-19 vaccines against the Mu variant, although he acknowledged that the third booster dose was found to be very effective against all stra...
coronavirus, Noticias, Pfizer, Salud, tercera dosis, vacuna, Variante Delta

Pfizer: High Efficacy of Third Dose Against Delta Variant | Digital Trends Spanish

Pfizer / BioNTech released new data suggesting that the third dose of their COVID-19 vaccine causes strong protection against the Delta variant. Because of this, the pharmaceutical company indicated that it expects to request the authorization of emergency use for a booster injection starting in August. The data published by the firm indicate that the levels of antibodies against the Delta variant in people aged 18 to 55 years who receive a third dose, are more than five times higher than after a second dose vaccine. Meanwhile, among people 65 to 85 years old, the company's data suggests that antibody levels against the variant after receiving a third dose are eleven times higher than after a second dose. According to Pfizer, there is an "estimated potential for up to a 100-fold increas...